SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is trending as its community leverages high social engagement and steady, organic growth to push toward new market cap milestones. Supporters are actively discussing their long-term conviction in the project, emphasizing its transparency and community-driven approach as key differentiators in the memecoin market.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

The Buttcoin community is rallying behind a long-standing narrative that positions the token as a cultural counterpoint to traditional assets, driven by its 2011 origin story and status as an early pioneer in the parody coin space. Supporters are actively discussing a transition toward a more formal ecosystem, emphasizing the coin's historical persistence and growing adoption as primary catalysts for its future potential.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

Ghost is trending as community members debate its potential as a privacy-focused utility token on the Solana network versus persistent accusations of it being a pump-and-dump scheme. Discussions are polarized between investors promoting it as an undervalued gem with upcoming project milestones and critics labeling it a slow rug pull.

Invitation Homes, Inc. engages in the acquisition, renovation, leasing, and operation of single-family homes as rental properties, including single-family homes in planned unit developments. Its services include property management, selection of homes, maintenance program, and online payment. The company was founded by Marcus Ridgway, Dallas Tanner, and Brad Greiwe in 2012 and is headquartered in Dallas, TX.

Invitation Homes Inc

Invitation Homes is garnering attention as the broader housing sector faces intense scrutiny over the impact of institutional ownership on home affordability. Investors are closely monitoring its performance against a backdrop of potential policy shifts, fluctuating interest rates, and internal growth initiatives like new development partnerships.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems is trending due to anticipation of the CHOPIN trial data, which is set to be presented as a late-breaking abstract at ESMO. While the community is frustrated by recent stock volatility and revenue guidance adjustments, sentiment remains highly focused on the potential for clinical trial success to expand the Hepzato Kit's standard-of-care position and drive long-term value.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating intense community interest due to its ultra-low circulating supply and potential for price appreciation within the NFT and DeFi sectors. Investors are actively discussing the possibility of a supply shock and a significant breakout, with many advocating for accumulation despite recent volatility and skepticism.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors highlight the project's 'phygital' strategy, noting its physical presence in major retail stores and the recent launch of a Visa-backed spending card. Community sentiment remains polarized, with many holders aggressively accumulating during price dips while others express frustration over the token's inability to decouple from broader market volatility.

WorldFinancial

WorldFinancial (WLFI) is seeing intense volatility and social media debate as investors react to a Congressional probe into the projects foreign investment deals and ongoing concerns regarding governance and transparency. While some community members view the current price action as an accumulation opportunity ahead of upcoming crypto forums and product milestones, others remain highly skeptical, labeling the token a speculative grift that heavily relies on the Trump family brand.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending following an appeals court ruling that could significantly reduce its wildfire-related liabilities, while investors continue to debate the company's direction under new CEO Greg Abel. The community is actively discussing the stock's recent underperformance relative to the broader market, with many questioning the firm's capital allocation strategy and the long-term effectiveness of its massive cash pile.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

Aircoin is gaining significant traction on the Solana network, with the community highlighting its long-term project viability, consistent daily activity, and a voluntary supply-locking mechanism. Supporters are actively focused on the project's 'PvE' narrative, emphasizing deep conviction, doxxed leadership, and steady growth over short-term hype.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire REHOVOT, Israel, March 26, 2026 REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlantBiotechnologies (Nasdaq...

CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement PR Newswire REHOVOT...

CollPlant Biotechnologies Launches Redesigned Corporate Website

CollPlant Biotechnologies Launches Redesigned Corporate Website CollPlant Biotechnologies Launches Redesigned Corporate Website PR Newswire REHOVOT, Israel, March 18, 2026 REHOVOT, Israel, March 18...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS PR Newswire REHOVOT, Israel, March 11, 2026...

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler

CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal...

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex

CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex PR Newswire...

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments

CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments PR Newswire REHOVOT, Israel, Feb. 17, 2026...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING

COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING PR Newswire REHOVOT, Israel, Feb. 5, 2026...

<ul class="summary-bullets"><li>The workforce reduction plan is expected to impact 25% of the company’s workforce.</li><li>The company’s adjusted net loss per share in Q3 came in at $0.25, but analysts, on average, expected earnings of $0.15 per share.</li><li>The company reported revenue of $77,000 for the three months ended September.</li></ul>Shares of CollPlant Biotechnologies (CLGN) slumped 14% on Wednesday morning after the company reported third-quarter earnings below Wall Street expectations.The firm <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/collplant-biotechnologies-reports-2025-third-quarter-financial-results-and-provides-corporate-update-302626666.html">reported</a> revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to data from Fiscal AI.Adjusted net loss per share came in at $0.25, lower than the $0.33 loss reported in the corresponding quarter of 2024. Still, analysts, on average, were expecting the company to report earnings of $0.15 per share.<h2 class="st-heading-2">Cost-Cutting Efforts And Layoffs</h2>The company said it has initiated a cost-cutting and workforce-reduction plan, which is expected to result in about a 25% cut in its workforce."In 2026, CollPlant will prioritize its collaboration with AbbVie and continue advancing its own dermal filler product candidate… In parallel, we plan to actively seek a strategic partner to collaborate with us on the continued development of our novel regenerative breast implant product candidate," Collplant CEO Yehiel Tal said.CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The company's products are based on its recombinant human collagen. The company entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, in 2021."We remain highly encouraged by the additional results emerging from the preclinical studies of our commercial-size regenerative breast implants, as well as from the ongoing evaluations of our photocurable dermal filler program,” Tal added. The photocurable derma filler program is now in the final stages of preclinical testing, and the company is now preparing for the initial clinical studies, IT said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, the retail sentiment around <a href="https://stocktwits.com/symbol/CLGN">CLGN stock</a> stayed within the ‘bullish’ territory over the past 24 hours while message volume rose from ‘low’ to ‘normal’ levels.CLGN stock is down 44% this year and by about 53% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nyxoah-sa-stock-rises-pre-market-after-cms-raises-reimbursement-for-sleep-disorder-therapy/cL538b3REWB">Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, a smartphone displays the logo of CollPlant Biotechnologies Ltd., an Israel-based regenerative and aesthetic medicine company, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention

The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to data from Fiscal AI. 

Equity

The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to data from Fiscal AI. 


COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE...

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

CLGN
CollPlant Biotechnologies Ltd - Ordinary Shares New

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CLGN News

CLGNCollPlant Biotechnologies Ltd - Ordinary Shares New